Control of Blood Pressure After Stroke

Bath, Philip M.W.; Sprigg, Nikola

doi:10.1161/01.hyp.0000230663.32521.0d

Cited by 5 publications

(4 citation statements)

References 11 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The conclusion after this meta-analysis was that lowering blood pressure is an effective method for reducing the risk of subsequent stroke. Most patients will need ≥2 drugs, and combinations should be logical and based on class pharmacological activities (especially taking into account effects on the renin system) [62]. …”

Section: Secondary Preventionmentioning

confidence: 99%

Primary and Secondary Prevention of Ischemic Stroke

Paciaroni¹,

Bogousslavsky²

2010

Eur Neurol

View full text Add to dashboard Cite

Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy) and more specific interventions, such as carotid revascularization or anticoagulation for atrial fibrillation. The objective of this review is to discuss effective interventions for optimal primary and secondary stroke prevention.

show abstract

Section: Secondary Preventionmentioning

confidence: 99%

Primary and Secondary Prevention of Ischemic Stroke

Paciaroni¹,

Bogousslavsky²

2010

Eur Neurol

View full text Add to dashboard Cite

show abstract

“…4,5 Presently, for secondary prevention of stroke, achieving a target BP of 130/80 mm Hg with a combination of any available antihypertensive drugs is recommended. [5][6][7][8][9] Despite this, there is consistent evidence to suggest that BP is poorly controlled in a proportion of this high-risk as long as 5 years after stroke. [7][8][9] The North East Melbourne Stroke Incidence Study (NEMESIS) trial reported that 37% of hypertensive 5-year stroke survivors had above target BP readings, and that 18% were not taking any antihypertensive medications.…”

Section: Stroke and Blood Pressure Loweringmentioning

confidence: 99%

“…[5][6][7][8][9] Despite this, there is consistent evidence to suggest that BP is poorly controlled in a proportion of this high-risk as long as 5 years after stroke. [7][8][9] The North East Melbourne Stroke Incidence Study (NEMESIS) trial reported that 37% of hypertensive 5-year stroke survivors had above target BP readings, and that 18% were not taking any antihypertensive medications. 9 Although the reasons for poor BP control in this population are likely to be complex, emergent populations of both difficult-to-treat and resistant hypertensives are likely to contribute to this effect, 10 as is the side-effect profile associated with commonly prescribed antihypertensives.…”

Section: Stroke and Blood Pressure Loweringmentioning

confidence: 99%

Potassium Intake and Stroke Risk

Hunt

Cappuccio

2014

Stroke

View full text Add to dashboard Cite

“…The conclusion after this meta-analysis was that lowering blood pressure is an effective method for reducing the risk of subsequent stroke. Most patients will need 2 drugs, and combination should be logical and based on class pharmacological activities, especially taking account of effects on the renin system [53].…”

Section: Summary Of the Benefit Of Different An-tihypertensive Drug Cmentioning

confidence: 99%

Are there Differences in Stroke Prevention with Different Blood Pressure Lowering Agents?

Paciaroni¹,

Bogousslavsky

2009

CHYR

View full text Add to dashboard Cite

Hypertension is the major modifiable risk factor for fatal, nonfatal strokes and other vascular diseases. In a pooled analysis of 61 prospective studies including about one million individuals, the reported risk of stroke increased progressively with blood pressure from values as low as 115/75 mm/Hg. Each increment of 20/10 mm/Hg doubles the risk of cardiovascular disease and such a correlation is consistent at all ages. Blood pressure lowering strongly reduces the risk of either first stroke or recurrent stroke but the possibility that specific drugs may prevail over others for protection from stroke remains unclear. There is some evidence that specific classes of antihypertensive drugs have different effects and/or their pharmacological actions differ in patient subgroups. Currently, there are five classes of first-line blood pressure lowering drugs: diuretics, beta-blockers, calcium channel blockers, angiotensin-converting inhibitors and angiotensin II receptor blockers. This review evaluates the development of antihypertensive therapies and the latest studies of arterial hypertension and stroke prevention.

show abstract

Control of Blood Pressure After Stroke

Cited by 5 publications

References 11 publications

Primary and Secondary Prevention of Ischemic Stroke

Primary and Secondary Prevention of Ischemic Stroke

Potassium Intake and Stroke Risk

Are there Differences in Stroke Prevention with Different Blood Pressure Lowering Agents?

Contact Info

Product

Resources

About